The Directorate General of Foreign Trade (DGFT) issued Public Notice No. 36/2026-27 dated 23 October 2026, introducing four new Standard Input-Output Norms (SION) under Chemical and Allied Products (Product Code ‘A’).
These new norms aim to facilitate faster issuance of Advance Authorization and ensure uniformity in applying input-output norms.
Details of New SION Entries
DGFT has notified the following four SION entries:
- A-3715: Doxycycline Tablets USP 50 MG, 100 tablets per pack.
- A-3716: Doxycycline Tablets USP 100 MG, 50 tablets per pack.
- A-3717: Doxycycline Tablets USP 100 MG, 500 tablets per pack.
- A-3718: Clobetasol Propionate BP/EP/USP.
The notice specifies the corresponding input quantities for each product under the newly notified Standard Input-Output Norms (SION), helping exporters verify the applicable requirements for Advance Authorisation.
Impact on Exporters
These new SION norms are relevant to pharmaceutical manufacturers and exporters applying for Advance Authorisation. Exporters should review the applicable product specifications and input-output norms before submitting their applications.
The new entries are intended to support faster processing by DGFT Regional Authorities and promote consistent application of the norms.
Conclusion
Pharmaceutical exporters should review DGFT Public Notice 36/2026-27 and verify the applicable SION entry before applying for Advance Authorisation.